Frédéric B Piel1, Thomas V Adamkiewicz2, Djesika Amendah3, Thomas N Williams4,5, Sunetra Gupta1, Scott D Grosse6. 1. Department of Zoology, University of Oxford, Oxford, UK. 2. Department of Family Medicine, Morehouse School of Medicine, Atlanta, Georgia, USA. 3. African Population and Health Research Center, Nairobi, Kenya. 4. Kenya Medical Research Institute-Wellcome Trust Programme, Centre for Geographic Medicine Research-Coast, Kilifi District Hospital, Kilifi, Kenya. 5. Department of Medicine, Imperial College, St Mary's Hospital, London, UK. 6. National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Abstract
PURPOSE: Our objective was to compare observed and expected genotype proportions from newborn screening surveys of structural hemoglobin variants. METHODS: We conducted a systematic review of newborn screening surveys of hemoglobins S and C in Africa and the Middle East. We compared observed frequencies to those expected assuming Hardy-Weinberg equilibrium (HWE). Significant deviations were identified by an exact test. The fixation index FIS was calculated to assess excess homozygosity. We compared newborn estimates corrected and uncorrected for HWE deviations using demographic data. RESULTS: Sixty samples reported genotype counts for hemoglobin variants in Africa and the Middle East. Observed and expected counts matched in 27%. The observed number of sickle cell anemia (SCA) individuals was higher than expected in 42 samples, reaching significance (P < 0.05) in 24. High FIS values were common across the study regions. The estimated total number of newborns with SCA, corrected based on FIS, was 33,261 annual births instead of 24,958 for the 38 samples across sub-Saharan Africa and 1,109 annual births instead of 578 for 12 samples from the Middle East. CONCLUSION: Differences between observed and expected genotype frequencies are common in surveys of hemoglobin variants in the study regions. Further research is required to identify and quantify factors responsible for such deviations. Estimates based on HWE might substantially underestimate the annual number of SCA-affected newborns (up to one-third in sub-Saharan Africa and one-half in the Middle East).
PURPOSE: Our objective was to compare observed and expected genotype proportions from newborn screening surveys of structural hemoglobin variants. METHODS: We conducted a systematic review of newborn screening surveys of hemoglobins S and C in Africa and the Middle East. We compared observed frequencies to those expected assuming Hardy-Weinberg equilibrium (HWE). Significant deviations were identified by an exact test. The fixation index FIS was calculated to assess excess homozygosity. We compared newborn estimates corrected and uncorrected for HWE deviations using demographic data. RESULTS: Sixty samples reported genotype counts for hemoglobin variants in Africa and the Middle East. Observed and expected counts matched in 27%. The observed number of sickle cell anemia (SCA) individuals was higher than expected in 42 samples, reaching significance (P < 0.05) in 24. High FIS values were common across the study regions. The estimated total number of newborns with SCA, corrected based on FIS, was 33,261 annual births instead of 24,958 for the 38 samples across sub-Saharan Africa and 1,109 annual births instead of 578 for 12 samples from the Middle East. CONCLUSION: Differences between observed and expected genotype frequencies are common in surveys of hemoglobin variants in the study regions. Further research is required to identify and quantify factors responsible for such deviations. Estimates based on HWE might substantially underestimate the annual number of SCA-affected newborns (up to one-third in sub-Saharan Africa and one-half in the Middle East).
Authors: Mohammad I El-Mouzan; Abdullah A Al-Salloum; Abdullah S Al-Herbish; Mansour M Qurachi; Ahmad A Al-Omar Journal: Saudi Med J Date: 2007-12 Impact factor: 1.484
Authors: D Modiano; G Luoni; B S Sirima; J Simporé; F Verra; A Konaté; E Rastrelli; A Olivieri; C Calissano; G M Paganotti; L D'Urbano; I Sanou; A Sawadogo; G Modiano; M Coluzzi Journal: Nature Date: 2001-11-15 Impact factor: 49.962
Authors: Frédéric B Piel; Anand P Patil; Rosalind E Howes; Oscar A Nyangiri; Peter W Gething; Mewahyu Dewi; William H Temperley; Thomas N Williams; David J Weatherall; Simon I Hay Journal: Lancet Date: 2012-10-25 Impact factor: 79.321
Authors: Amanda R Burnham-Marusich; Chinenye O Ezeanolue; Michael C Obiefune; Wei Yang; Alice Osuji; Amaka G Ogidi; Aaron T Hunt; Dina Patel; Echezona E Ezeanolue Journal: Public Health Genomics Date: 2016-09-10 Impact factor: 2.000
Authors: Emmanuela E Ambrose; Julie Makani; Neema Chami; Tulla Masoza; Rogatus Kabyemera; Robert N Peck; Erasmus Kamugisha; Alphaxard Manjurano; Neema Kayange; Luke R Smart Journal: Pediatr Blood Cancer Date: 2017-08-02 Impact factor: 3.167
Authors: Festus K Acquah; Dickson Donu; Dorcas Bredu; Sophia Eyia-Ampah; Jones A Amponsah; Joseph Quartey; Evans K Obboh; Bernice A Mawuli; Linda E Amoah Journal: Malar J Date: 2020-06-23 Impact factor: 2.979
Authors: Emmanuela E Ambrose; Luke R Smart; Mwesige Charles; Arielle G Hernandez; Teresa Latham; Adolfine Hokororo; Medard Beyanga; Thad A Howard; Erasmus Kamugisha; Kathryn E McElhinney; Erius Tebuka; Russell E Ware Journal: Bull World Health Organ Date: 2020-09-28 Impact factor: 13.831
Authors: Giovana R Weber Hoss; Fernanda Sperb-Ludwig; Ida V D Schwartz; Henk J Blom Journal: Mol Genet Genomic Med Date: 2020-03-30 Impact factor: 2.183